Open AccessEffectiveness and safety of sorafenib 400 mg vs. 800 mg initial dose on survival in patients with advanced and intermediate stage hepatocellular carcinoma: A systematic review and meta-analysis
Author(s) -
RolHELMIZAR,
Juferdy Kurniawan
Publication year - 2022
Publication title -
annals of hepato-biliary-pancreatic surgery
Language(s) - English
Resource type - Journals
eISSN - 2508-5859
pISSN - 2508-5778
DOI - 10.14701/ahbps.2022s1.ep-32
Subject(s) - sorafenib , meta analysis , hepatocellular carcinoma , medicine , oncology , stage (stratigraphy) , urology , biology , paleontology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom